» Articles » PMID: 28413633

Pluripotent Stem Cells to Hepatocytes, the Journey So Far

Overview
Journal Biomed Rep
Specialty Biochemistry
Date 2017 Apr 18
PMID 28413633
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past several years, there has been substantial progress in the field of regenerative medicine, which has enabled new possibilities for research and clinical application. For example, there are ongoing efforts directed at generating functional hepatocytes from adult-derived pluripotent cells for toxicity screening, generating disease models or, in the longer term, for the treatment of liver failure. In the present review, the authors summarise recent developments in regenerative medicine and pluripotent stem cells, the methods and tissues used for reprogramming and the differentiation of induced pluripotent stem cells (iPSCs) into hepatocyte-like cells. In addition, the hepatic disease models developed using iPSC technologies are discussed, as well as the potential for gene editing.

Citing Articles

Liver organoids: updates on generation strategies and biomedical applications.

Liu S, Cheng C, Zhu L, Zhao T, Wang Z, Yi X Stem Cell Res Ther. 2024; 15(1):244.

PMID: 39113154 PMC: 11304926. DOI: 10.1186/s13287-024-03865-3.


Pluripotent Stem Cell-Derived Hepatocyte-like Cells: Induction Methods and Applications.

Luo Q, Wang N, Que H, Mai E, Hu Y, Tan R Int J Mol Sci. 2023; 24(14).

PMID: 37511351 PMC: 10380504. DOI: 10.3390/ijms241411592.


Liver Organoid Potential Application for Hepatitis E Virus Infection.

Xiang K, Zhuang H Adv Exp Med Biol. 2023; 1417:133-139.

PMID: 37223863 DOI: 10.1007/978-981-99-1304-6_9.


Therapeutic effect of autologous bone marrow cells injected into the liver under the guidance of B‑ultrasound in the treatment of HBV‑related decompensated liver cirrhosis.

Li L, Si Y, Cheng M, Lang L, Li A, Liu B Exp Ther Med. 2022; 24(4):633.

PMID: 36160909 PMC: 9468850. DOI: 10.3892/etm.2022.11570.


Generation of functional hepatocytes by forward programming with nuclear receptors.

Tomaz R, Zacharis E, Bachinger F, Wurmser A, Yamamoto D, Petrus-Reurer S Elife. 2022; 11.

PMID: 35959725 PMC: 9374437. DOI: 10.7554/eLife.71591.


References
1.
Diederichs S, Tuan R . Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. Stem Cells Dev. 2014; 23(14):1594-610. PMC: 4086513. DOI: 10.1089/scd.2013.0477. View

2.
Yusa K, Rashid S, Strick-Marchand H, Varela I, Liu P, Paschon D . Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature. 2011; 478(7369):391-4. PMC: 3198846. DOI: 10.1038/nature10424. View

3.
Kanninen L, Harjumaki R, Peltoniemi P, Bogacheva M, Salmi T, Porola P . Laminin-511 and laminin-521-based matrices for efficient hepatic specification of human pluripotent stem cells. Biomaterials. 2016; 103:86-100. DOI: 10.1016/j.biomaterials.2016.06.054. View

4.
Siller R, Greenhough S, Naumovska E, Sullivan G . Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells. Stem Cell Reports. 2015; 4(5):939-52. PMC: 4437467. DOI: 10.1016/j.stemcr.2015.04.001. View

5.
Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C . Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol. 2006; 24(6):687-96. DOI: 10.1038/nbt1216. View